New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...
Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
As the fall immunization season begins, physicians are turning to multiple strategies to get shots into arms as they juggle ...